Trial Profile
Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Malignant thymoma; Thymic epithelial tumour
- Focus Adverse reactions; Therapeutic Use
- 03 Nov 2015 New trial record
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer